High materiality9/10
Arcutis Biotherapeutics initiated with an Overweight at Cantor Fitzgerald
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Cantor Fitzgerald initiates ARQT with Overweight; target $48; current price $26.41.
- Target: $48; Price: $26.41; Firm: Cantor Fitzgerald
Key facts
- 01
Target: $48
- 02
Posted price: $26.41
- 03
Analyst firm: Cantor Fitzgerald
- 04
Analyst: Steve Seedhouse
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.